T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
REVG
2051
DELISTED
REV Group
REVG
| $819K | ﹤0.01% |
25,698
-32,060
| -56% | -$953K |
|
2052
Ginkgo Bioworks
DNA
$486M
| $814K | ﹤0.01% |
82,815
+3,152
| +4% | +$27K |
|
2053
Liquidity Services
LQDT
$1.35B
| $812K | ﹤0.01% |
25,123
+3,696
| +17% | +$93.7K |
|
2054
Schrodinger
SDGR
$1.38B
| $811K | ﹤0.01% |
42,009
+3,376
| +9% | +$65.6K |
|
2055
OneSpan
OSPN
$609M
| $808K | ﹤0.01% |
43,566
-6,666
| -13% | -$113K |
|
2056
Liberty Live Group Series A
LLYVA
$9.59B
| $805K | ﹤0.01% |
12,081
-6,647
| -35% | -$412K |
|
2057
REX American Resources
REX
$1.44B
| $805K | ﹤0.01% |
38,574
+452
| +1% | +$9.99K |
|
|
BRSL
2058
Brightstar Lottery PLC
BRSL
$2.15B
| $804K | ﹤0.01% |
45,480
+8,295
| +22% | +$163K |
|
|
WNS
2059
DELISTED
WNS Holdings
WNS
| $802K | ﹤0.01% |
16,906
+2,137
| +14% | +$105K |
|
|
LADR
2060
Ladder Capital
LADR
$1.25B
| $799K | ﹤0.01% |
71,397
+6,714
| +10% | +$77.1K |
|
2061
Fidelity MSCI Information Technology Index ETF
FTEC
$21.6B
| $796K | ﹤0.01% |
4,302
| – | – |
|
|
GRSD
2062
Grandstand Limited Ordinary Shares
GRSD
$67.3M
| $794K | ﹤0.01% |
+56,342
| New | +$663K |
|
2063
The RMR Group
RMR
$337M
| $794K | ﹤0.01% |
38,443
+4,910
| +15% | +$114K |
|
|
LGF.B
2064
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $793K | ﹤0.01% |
104,997
+11,978
| +13% | +$84K |
|
2065
AMN Healthcare
AMN
$1.34B
| $791K | ﹤0.01% |
33,045
+2,597
| +9% | +$82.5K |
|
2066
Worthington Steel
WS
$1.94B
| $791K | ﹤0.01% |
24,849
+1,331
| +6% | +$51.9K |
|
2067
OneSpaWorld
OSW
$2.73B
| $786K | ﹤0.01% |
39,448
+6,607
| +20% | +$123K |
|
|
PRA
2068
DELISTED
ProAssurance
PRA
| $783K | ﹤0.01% |
49,155
+2,993
| +6% | +$47.6K |
|
2069
SunCoke Energy
SXC
$801M
| $783K | ﹤0.01% |
73,107
+5,595
| +8% | +$60K |
|
2070
Pacira BioSciences
PCRX
$924M
| $779K | ﹤0.01% |
41,306
-9,409
| -19% | -$165K |
|
2071
Grid Dynamics Holdings
GDYN
$632M
| $777K | ﹤0.01% |
34,917
+6,815
| +24% | +$119K |
|
2072
Edgewise Therapeutics
EWTX
$4.73B
| $776K | ﹤0.01% |
29,050
+5,242
| +22% | +$167K |
|
|
BRSP
2073
BrightSpire Capital
BRSP
$628M
| $775K | ﹤0.01% |
137,369
+19,184
| +16% | +$113K |
|
|
RC
2074
Ready Capital
RC
$289M
| $775K | ﹤0.01% |
113,629
+11,922
| +12% | +$85.7K |
|
|
ARI
2075
Apollo Commercial Real Estate
ARI
$885M
| $774K | ﹤0.01% |
89,372
-4,502
| -5% | -$40.5K |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.